Intercept Pharma (ICPT) Tops Q1 EPS by 64c

Intercept Pharma (NASDAQ: ICPT) reported Q1 EPS of ($3.61), $0.64 better than the analyst estimate of ($4.25). Revenue for the quarter came in at $21 million versus the consensus estimate of $15.8 million.

For earnings history and earnings-related data on Intercept Pharma (ICPT) click here.

You May Also Be Interested In

• Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
• Brandywine Realty Trust (BDN) Reports In-Line Q1 EPS, provides guidance
• Logansport Financial Corp. (LOGN) Reports Q1 EPS of $0.44